• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哪些慢性阻塞性肺疾病患者会从咳嗽监测中获益?

Which Patients with COPD Would Benefit from Cough Monitoring?

作者信息

den Brinker Albertus C, Thackray-Nocera Susannah, Crooks Michael G, Morice Alyn H

机构信息

Independent Researcher, NL-5708 DJ Helmond, The Netherlands.

Centre for Clinical Science, Hull York Medical School, University of Hull, Cottingham HU16 5JQ, UK.

出版信息

J Clin Med. 2025 Jun 25;14(13):4506. doi: 10.3390/jcm14134506.

DOI:10.3390/jcm14134506
PMID:40648880
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12249659/
Abstract

Cough monitoring for exacerbation detection is optimally effective if used for the appropriate cohort of chronic obstructive pulmonary disease (COPD) patients, i.e., increased cough during exacerbation and prodrome is a prerequisite enabling (early) detection. A post hoc analysis of data from a validation study on an alert system for exacerbation detection based on nighttime cough was used to study if patient data were predictive for the increased cough during exacerbation and for cough count distribution. The quantitative effect on the performance of the alert system when using patient stratification was studied as well. Patient data were not predictive for robust cough statistics: neither the nighttime cough count median nor the interquartile range were found to have statistically relevant correlation with the available patient data. Patients with and without increased cough during exacerbation did show differences in their characteristics. Using patient age and symptom questionnaire data, a classifier based on a logistic regression model was parametrised having an accuracy of 85% in predicting presence or absence of increased cough during exacerbation. Using the classifier for patient stratification, the performance of the exacerbation alert system increased with sensitivity going from 59 to 76%. The post hoc analysis suggests that patient data can be used to stratify COPD patients for cough monitoring.

摘要

如果将咳嗽监测用于慢性阻塞性肺疾病(COPD)患者的适当队列,以检测病情加重,那么它将具有最佳效果,即病情加重和前驱期咳嗽增加是(早期)检测的先决条件。基于夜间咳嗽的病情加重警报系统验证研究的数据进行了事后分析,以研究患者数据是否可预测病情加重期间咳嗽增加以及咳嗽计数分布情况。还研究了使用患者分层时对警报系统性能的定量影响。患者数据无法预测可靠的咳嗽统计数据:夜间咳嗽计数中位数和四分位数间距均与可用患者数据无统计学上的相关关联。病情加重期间咳嗽增加和未增加的患者在特征上确实存在差异。利用患者年龄和症状问卷数据,基于逻辑回归模型的分类器得以参数化,在预测病情加重期间咳嗽增加与否方面的准确率为85%。使用该分类器进行患者分层,病情加重警报系统的性能有所提高,敏感性从59%提高到76%。事后分析表明,患者数据可用于对COPD患者进行分层以进行咳嗽监测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5cd/12249659/c79f83aa4c14/jcm-14-04506-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5cd/12249659/21d2da546500/jcm-14-04506-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5cd/12249659/397b716b741e/jcm-14-04506-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5cd/12249659/f8526edfa522/jcm-14-04506-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5cd/12249659/75ddf3ea3f8b/jcm-14-04506-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5cd/12249659/c79f83aa4c14/jcm-14-04506-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5cd/12249659/21d2da546500/jcm-14-04506-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5cd/12249659/397b716b741e/jcm-14-04506-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5cd/12249659/f8526edfa522/jcm-14-04506-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5cd/12249659/75ddf3ea3f8b/jcm-14-04506-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5cd/12249659/c79f83aa4c14/jcm-14-04506-g005.jpg

相似文献

1
Which Patients with COPD Would Benefit from Cough Monitoring?哪些慢性阻塞性肺疾病患者会从咳嗽监测中获益?
J Clin Med. 2025 Jun 25;14(13):4506. doi: 10.3390/jcm14134506.
2
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
3
Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD).远程医疗干预:针对慢性阻塞性肺疾病(COPD)患者的远程监测和咨询。
Cochrane Database Syst Rev. 2021 Jul 20;7(7):CD013196. doi: 10.1002/14651858.CD013196.pub2.
4
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
6
Intraoperative frozen section analysis for the diagnosis of early stage ovarian cancer in suspicious pelvic masses.术中冰冻切片分析用于诊断可疑盆腔肿块中的早期卵巢癌。
Cochrane Database Syst Rev. 2016 Mar 1;3(3):CD010360. doi: 10.1002/14651858.CD010360.pub2.
7
Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者自我管理干预措施(包括针对病情加重的行动计划)与常规护理的比较。
Cochrane Database Syst Rev. 2017 Aug 4;8(8):CD011682. doi: 10.1002/14651858.CD011682.pub2.
8
Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease.免疫刺激剂与安慰剂在预防慢性支气管炎或慢性阻塞性肺疾病成人恶化中的比较。
Cochrane Database Syst Rev. 2022 Nov 14;11(11):CD013343. doi: 10.1002/14651858.CD013343.pub2.
9
Sputum colour charts to guide antibiotic self-treatment of acute exacerbation of chronic obstructive pulmonary disease: the Colour-COPD RCT.用于指导慢性阻塞性肺疾病急性加重期抗生素自我治疗的痰液颜色图表:Colour-COPD随机对照试验
Health Technol Assess. 2025 May;29(28):1-42. doi: 10.3310/KPFD5558.
10
A New Measure of Quantified Social Health Is Associated With Levels of Discomfort, Capability, and Mental and General Health Among Patients Seeking Musculoskeletal Specialty Care.一种新的量化社会健康指标与寻求肌肉骨骼专科护理的患者的不适程度、能力以及心理和总体健康水平相关。
Clin Orthop Relat Res. 2025 Apr 1;483(4):647-663. doi: 10.1097/CORR.0000000000003394. Epub 2025 Feb 5.

引用本文的文献

1
Improved Precision of COPD Exacerbation Detection in Night-Time Cough Monitoring.夜间咳嗽监测中慢性阻塞性肺疾病急性加重检测精度的提高
J Pers Med. 2025 Aug 2;15(8):349. doi: 10.3390/jpm15080349.

本文引用的文献

1
Can Passive Cough Monitoring Predict COPD Exacerbations?被动咳嗽监测能否预测慢性阻塞性肺疾病急性加重?
COPD. 2025 Apr 4;22(1):2487909. doi: 10.1080/15412555.2025.2487909. Epub 2025 Apr 14.
2
Cough monitoring systems in adults with chronic respiratory diseases: a systematic review.慢性呼吸道疾病成人患者的咳嗽监测系统:一项系统综述
Eur Respir Rev. 2025 Mar 5;34(175). doi: 10.1183/16000617.0212-2023. Print 2025 Jan.
3
Longitudinal Cough Frequency Monitoring in Persistent Coughers: Daily Variability and Predictability.持续性咳嗽患者的纵向咳嗽频率监测:日变化和可预测性。
Lung. 2024 Oct;202(5):561-568. doi: 10.1007/s00408-024-00734-x. Epub 2024 Jul 31.
4
Development of a daily predictive model for the exacerbation of chronic obstructive pulmonary disease.开发一种用于预测慢性阻塞性肺疾病恶化的每日预测模型。
Sci Rep. 2023 Oct 31;13(1):18669. doi: 10.1038/s41598-023-45835-4.
5
The Development of a COPD Exacerbation Recognition Tool (CERT) to Help Patients Recognize When to Seek Medical Advice.慢性阻塞性肺疾病加重识别工具(CERT)的开发,以帮助患者识别何时需要寻求医疗建议。
Int J Chron Obstruct Pulmon Dis. 2022 Jan 21;17:213-222. doi: 10.2147/COPD.S337644. eCollection 2022.
6
Validation of COPDPredict™: Unique Combination of Remote Monitoring and Exacerbation Prediction to Support Preventative Management of COPD Exacerbations.验证 COPDPredictTM:远程监测和加重预测的独特组合,支持 COPD 加重的预防管理。
Int J Chron Obstruct Pulmon Dis. 2021 Jun 21;16:1887-1899. doi: 10.2147/COPD.S309372. eCollection 2021.
7
Advances in Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病进展。
Annu Rev Med. 2021 Jan 27;72:119-134. doi: 10.1146/annurev-med-080919-112707.
8
Pinecone-Inspired Nanoarchitectured Smart Microcages Enable Nano/Microparticle Drug Delivery.受松果启发的纳米结构智能微笼实现纳米/微粒药物递送。
Adv Funct Mater. 2020 Jul 9;30(28):2002434. doi: 10.1002/adfm.202002434. Epub 2020 May 15.
9
Smoke-Free Policies and 30-Day Readmission Rates for Chronic Obstructive Pulmonary Disease.无烟政策与慢性阻塞性肺疾病 30 天再入院率。
Am J Prev Med. 2019 Nov;57(5):621-628. doi: 10.1016/j.amepre.2019.06.008. Epub 2019 Sep 27.
10
Validation of ACCESS: an automated tool to support self-management of COPD exacerbations.ACCESS的验证:一种支持慢性阻塞性肺疾病急性加重期自我管理的自动化工具。
Int J Chron Obstruct Pulmon Dis. 2018 Oct 10;13:3255-3267. doi: 10.2147/COPD.S167272. eCollection 2018.